BAT CEO Urges Anvisa to Advance E-Cigarette Regulation in Brazil

Regulations by 2FIRSTS.ai
Apr.17.2024
BAT CEO Urges Anvisa to Advance E-Cigarette Regulation in Brazil
BAT CEO Victor Loria hopes Brazil's health agency will regulate e-cigarettes in an upcoming meeting amid growing global acceptance.

According to Brazilian media Poder360, on April 16th, the CEO of British American Tobacco Brazil, Victor Loria, expressed his hope that Brazil's National Health Surveillance Agency (Anvisa) would advance regulations for e-cigarettes in Brazil. This issue will be discussed at a regulatory agency meeting on Thursday (April 17, 2024). In 2009, Anvisa banned the production and sale of e-cigarettes in Brazil, and maintained this decision in 2022.

 

Loria said that many things have changed during the past 15 years of the ban. In his view, if e-cigarettes are still prohibited, then Anvisa and Brazil will fall behind. According to studies he mentioned, e-cigarettes pose less health risks compared to traditional cigarettes, which is also a reason to consider regulating e-cigarettes.

 

Furthermore, Lorca stated that e-cigarettes are being regulated in multiple countries, which is another reason for reevaluating e-cigarettes. For example, in Chile, a bill was passed in October 2023. Currently, the products are undergoing regulatory procedures by the administrative department.

 

Loria emphasized the benefits of potential tax increases and decrease in traditional cigarette consumption that regulation, if approved, could bring. However, the World Health Organization's (WHO) director, Ruediger Krech, stated that he opposes the use of e-cigarettes.

 

By the time the public consultation by Anvisa on this issue ended in February 2024, the prevailing sentiment was against the ban.

 

Loria is currently responsible for overseeing the operation of BAT in countries such as Brazil, Argentina, Chile, Cuba, Paraguay, and Peru. In 2023, BAT reported a revenue of £27.3 million, with 14% coming from e-cigarettes. By 2035, they expect e-cigarette sales to account for 50% of total sales.

 

Loria told the media that the 15-year-old ban that has been in place since 2009 has not been effective. The situation in Brazil is very complex and even sad. We have 3 million inhaler users who are often hiding in the hands of organized crime and non-regular organizations.

 

He stated that the estimated turnover of e-cigarettes is 7.5 billion reais (including consumption), with nearly 5 billion reais in tax evasion in the illegal gray market. The state government projects are lacking funds to invest.

 

And we all know that advancing these projects is very important. It is expected that Anvisa will move towards regulating all of these things for the benefit of society.

 

He believes, "For us, it's primarily a substitute, precisely because it imitates cigarettes and brings consumers into a lower-risk category. But if there are any adults in the future who want to consume nicotine, they will have other options."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France remains one of Europe’s active vape markets in 2026, with adult vaping prevalence rising to 7.9%; at the same time, e-liquid taxation, public-space restrictions, advertising compliance and health-risk debate are pushing the industry into a critical policy period.
Jun.23
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate
Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate
Former ATF Deputy Director Edgar Domenech has warned that some Chinese vape companies may be using 6-methyl nicotine, a nicotine analogue, raising new questions over how US regulators should classify emerging nicotine compounds.
Jul.13